TerrAscend (TSNDF) Shares Outstanding (Weighted Average) (2020 - 2026)
TerrAscend (TSNDF) reported Shares Outstanding (Weighted Average) of $308.5 million for Q1 2026, up 5.26% year-over-year from $293.1 million in Q1 2025, and up 1226.82% quarter-over-quarter from $23.3 million in Q4 2025.
TerrAscend (TSNDF) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $308.5 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $308.5 million, up 5.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $308.5 million (up 5.26% YoY), and the FY2025 annual result was $301.1 million, up 1188.3% from the prior year.
- Shares Outstanding (Weighted Average) grew to $308.5 million in Q1 2026 per TSNDF's latest filing, from $23.3 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $308.5 million in Q1 2026 and troughed at $3.6 million in Q4 2023.
- A 5-year average of $144.5 million and a median of $127.7 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) tumbled 99.87% in 2022, then jumped 8064.21% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $244.4 million in 2022, then slumped by 98.53% to $3.6 million in 2023, then surged by 550.93% to $23.4 million in 2024, then dropped by 0.5% to $23.3 million in 2025, then jumped by 1226.82% to $308.5 million in 2026.
- Business Quant data shows TSNDF's Shares Outstanding (Weighted Average) at $308.5 million in Q1 2026, $23.3 million in Q4 2025, and $299.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | 308.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 308.53 Mn |
| Dec 31, 2025 | 23.25 Mn |
| Jun 30, 2025 | 299.09 Mn |
| Mar 31, 2025 | 293.12 Mn |
| Dec 31, 2024 | 23.37 Mn |
| Sep 30, 2024 | 23.56 Mn |
| Jun 30, 2024 | 291.49 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 3.59 Mn |
| Sep 30, 2023 | 10.72 Mn |
| Jun 30, 2023 | 10.72 Mn |
| Mar 31, 2023 | 267.21 Mn |
| Dec 31, 2022 | 244.35 Mn |
| Sep 30, 2022 | 254.36 Mn |
| Jun 30, 2022 | 231.83 Mn |
| Mar 31, 2022 | 23.29 Mn |
| Dec 31, 2021 | 31.00 Mn |
| Sep 30, 2021 | 179.44 Bn |
| Jun 30, 2021 | 182.37 Bn |
| Mar 31, 2021 | 171.37 Mn |